Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)
China
· Delayed Price · Currency is CNY 16.32
-0.08 (-0.49%)
Mar 11, 2026, 3:04 PM CST
SHE:300519 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,611 | 2,123 | 2,651 | 2,506 | 3,230 | 2,558 | Upgrade
|
| Market Cap Growth | 20.18% | -19.92% | 5.81% | -22.44% | 26.27% | 18.01% | Upgrade
|
| Enterprise Value | 1,921 | 1,454 | 1,957 | 1,801 | 2,555 | 1,921 | Upgrade
|
| Last Close Price | 16.32 | 13.00 | 15.72 | 14.43 | 17.94 | 13.76 | Upgrade
|
| PE Ratio | 46.73 | 42.14 | 41.20 | 23.03 | 28.27 | 25.85 | Upgrade
|
| PS Ratio | 10.16 | 7.93 | 9.81 | 7.13 | 10.07 | 9.04 | Upgrade
|
| PB Ratio | 3.15 | 2.56 | 3.14 | 2.92 | 3.82 | 3.09 | Upgrade
|
| P/TBV Ratio | 3.18 | 2.58 | 3.17 | 2.95 | 3.87 | 3.14 | Upgrade
|
| P/FCF Ratio | 40.43 | 44.02 | 71.07 | 22.82 | 25.31 | 25.00 | Upgrade
|
| P/OCF Ratio | 38.04 | 39.74 | 49.75 | 19.82 | 22.69 | 22.72 | Upgrade
|
| EV/Sales Ratio | 7.47 | 5.43 | 7.24 | 5.12 | 7.96 | 6.79 | Upgrade
|
| EV/EBITDA Ratio | 36.56 | 30.95 | 30.75 | 14.42 | 21.02 | 18.43 | Upgrade
|
| EV/EBIT Ratio | 51.24 | 45.38 | 40.05 | 16.25 | 23.50 | 20.95 | Upgrade
|
| EV/FCF Ratio | 29.74 | 30.14 | 52.46 | 16.41 | 20.02 | 18.77 | Upgrade
|
| Net Debt / Equity Ratio | -0.83 | -0.83 | -0.83 | -0.86 | -0.85 | -0.82 | Upgrade
|
| Net Debt / EBITDA Ratio | -13.15 | -14.66 | -10.98 | -5.90 | -5.91 | -6.49 | Upgrade
|
| Net Debt / FCF Ratio | -10.69 | -14.27 | -18.74 | -6.71 | -5.63 | -6.61 | Upgrade
|
| Asset Turnover | 0.29 | 0.29 | 0.29 | 0.37 | 0.35 | 0.32 | Upgrade
|
| Inventory Turnover | 2.66 | 2.53 | 2.72 | 3.66 | 3.24 | 2.79 | Upgrade
|
| Quick Ratio | 12.31 | 9.93 | 9.21 | 8.63 | 9.79 | 13.34 | Upgrade
|
| Current Ratio | 13.41 | 10.97 | 10.19 | 9.19 | 10.45 | 14.20 | Upgrade
|
| Return on Equity (ROE) | 7.04% | 6.02% | 7.56% | 12.76% | 13.66% | 12.17% | Upgrade
|
| Return on Assets (ROA) | 2.62% | 2.18% | 3.23% | 7.33% | 7.45% | 6.54% | Upgrade
|
| Return on Invested Capital (ROIC) | 23.19% | 19.71% | 32.20% | 76.99% | 67.83% | 48.73% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.50% | 3.80% | 5.70% | 12.70% | 12.70% | 10.90% | Upgrade
|
| Earnings Yield | 2.22% | 2.37% | 2.43% | 4.34% | 3.54% | 3.87% | Upgrade
|
| FCF Yield | 2.47% | 2.27% | 1.41% | 4.38% | 3.95% | 4.00% | Upgrade
|
| Dividend Yield | 1.83% | 2.31% | 2.54% | 3.47% | 3.34% | 4.36% | Upgrade
|
| Payout Ratio | 82.84% | 127.01% | 124.31% | 88.22% | 84.00% | 72.75% | Upgrade
|
| Buyback Yield / Dilution | -3.71% | -1.03% | -0.54% | 0.58% | -0.83% | -0.30% | Upgrade
|
| Total Shareholder Return | -1.83% | 1.28% | 2.01% | 4.04% | 2.52% | 4.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.